High-dose therapy and growth factor mobilized peripheral blood progenitor cell support for responding patients with metastatic breast cancer.

Stadtmauer, E A; Hodi, F S; Sickles, C; Biggs, D D; Mangan, P; Buzby, G; Zaleta, E; Silberstein, L

Stadtmauer, E A; Hodi, F S; Sickles, C; Biggs, D D; Mangan, P; Buzby, G; Zaleta, E; Silberstein, L.

Affiliation

Stadtmauer EA; Bone Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia.

Prog Clin Biol Res ; 389: 487-95, 1994.

Article in En | MEDLINE | ID: mdl-7535458

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Breast Neoplasms/drug therapy; Breast Neoplasms/therapy; Hematopoietic Stem Cell Transplantation; Adult; Blood Cells/cytology; Blood Cells/drug effects; Breast Neoplasms/secondary; Carboplatin/administration & dosage; Cyclophosphamide/administration & dosage; Female; Granulocyte Colony-Stimulating Factor/pharmacology; Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology; Hematopoiesis; Hematopoietic Cell Growth Factors/pharmacology; Hematopoietic Stem Cell Transplantation/adverse effects; Hematopoietic Stem Cells/cytology; Hematopoietic Stem Cells/drug effects; Humans; Middle Aged; Thiotepa/administration & dosage; Time Factors; Transplantation, Autologous

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation Limits: Adult / Female / Humans / Middle aged Language: En Journal: Prog Clin Biol Res Year: 1994 Type: Article

Search on Google

XML

PubMed Links